EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing

Nadja Bischoff, Sandra Wimberger, Ralf Kühn, Anne Laugesen, Volkan Turan, Brian Daniel Larsen, Claus Storgaard Sørensen, Kristian Helin, Eric Paul Bennett, Marcello Maresca, Cord Brakebusch

Gene and Genome Editing · 2023

DOI: 10.1016/j.ggedit.2022.100023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene and Genome Editing, 2023. Verfasst von Nadja Bischoff und 10 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alteration of specific epigenetic marks might promote homology directed repair (HDR) during CRISPR-Cas9 genome editing. Testing several epigenetic inhibitors in a traffic light reporter assay, the histone methylation inhibitor 3DZNep showed a significant HDR promoting effect, while non-homologous end joining mediated repair was not significantly changed. This HDR promoting effect was largely independent of the target gene and its expression levels but showed a limited cell type specificity. HDR promotion was independent of the best described target of 3DZNep, the H3K27 methyltransferase EZH2, and of altered gene expression, but correlated partially with increased frequency of S/G2 cell cycle stage.

Förderung

  • European Union

Zitieren

APA

Bischoff, N., Wimberger, S., Kühn, R., Laugesen, A., Turan, V., Larsen, B. D., Sørensen, C. S., Helin, K., Bennett, E. P., Maresca, M., & Brakebusch, C. (2023). The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing. Gene and Genome Editing. https://doi.org/10.1016/j.ggedit.2022.100023

Vancouver

Bischoff N, Wimberger S, Kühn R, Laugesen A, Turan V, Larsen BD, et al. The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing. Gene and Genome Editing. 2023. doi:10.1016/j.ggedit.2022.100023

BibTeX
@article{Bischoff2023,
  author = {Bischoff, Nadja and Wimberger, Sandra and Kühn, Ralf and Laugesen, Anne and Turan, Volkan and Larsen, Brian Daniel and Sørensen, Claus Storgaard and Helin, Kristian and Bennett, Eric Paul and Maresca, Marcello and Brakebusch, Cord},
  title = {The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing},
  journal = {Gene and Genome Editing},
  year = {2023},
  doi = {10.1016/j.ggedit.2022.100023}
}
Kostenlos starten →